TriVascular Technologies (TRIV) Misses Q4 EPS by 7c

TriVascular Technologies (NASDAQ: TRIV) reported Q4 EPS of ($0.72), $0.07 worse than the analyst estimate of ($0.65). Revenue for the quarter came in at $9.1 million versus the consensus estimate of $9.54 million.

For earnings history and earnings-related data on TriVascular Technologies (TRIV) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Reading (RDI) Tops Q2 EPS by 4c
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c